HealthFlex
×
  • Home
  • Past Events
    • 2023
      • Agenda
      • Speakers
      • Sponsors
      • Venue
    • 2024
      • Agenda
      • Speakers
      • Partners
      • Venue
    • 2025
      • Agenda
      • Speakers
      • Sponsors
      • Venue
  • Conference
    • Request Agenda
    • Speakers
    • Registration
    • Sponsorship
    • Media Partners
    • Poster Submission
    • Why should you attend?
    • Frequently Asked Questions
  • Gallery
    • Photo Report 2023
    • Photo Report 2024
    • Photo Report 2025
  • Contact
  • Register
Dalmaso Gilberto

Dalmaso Gilberto

Technical & Scientific Director at Palladio Consulting srl

Gilberto Dalmaso has over 35 years’ experience in pharmaceutical microbiology and sterility assurance, primarily with GlaxoSmithKline (GSK) where he started in 1984 with Glaxo Verona (Italy). During his distinguished career at GSK he led a series of technology-driven process improvements using scientific methods, while achieving GMP compliance and regulatory approvals.

Over his last five years with GSK, Gilberto led a series of initiatives implementing Process Analytical Technologies (PAT) and Rapid Microbial Methods (RMM) that improve quality and process understanding while yielding significant cost savings. In 2003, his laboratory gained the distinction of obtaining the world’s first rapid microbial PAT approval from the US FDA. In 2005, he obtained the first approval in Italy for parametric release of terminally sterilized products. In 2008, he obtained the first FDA approval for microbiological real-time release for a non-sterile clean liquid product. He finished his GSK career as a key member of the Aseptic QA & Biological Laboratories Group within the Quality Assurance Directorate.

Today Gilberto is the Technical & Scientific Director for Palladio Consulting srl. In this role he collaborates and consults with pharmaceutical companies to develop and implement science-based strategies and processes that utilize Quality by Design (QbD) principles to monitor, control, and improve the chemical, physical, and microbiological state of various production processes. He’s also a qualified training for the most important regulatory agencies. With his extensive experience in sterility assurance and microbiology, Gilberto has the capability of supporting pharmaceutical manufacturers in a wide variety of aseptic processes, machinery, regulations interpretation and method.

The BioTech Pharma Summit brings together the movers and shakers in Pharma & Biotech industry from several areas. Uniting niche and top buyers and sellers.

(+351) 915 239 640

client@genapsummit.com

https://biotechpharmasummit.com

Av. da República 676 Office 2, 4430-190 Vila Nova de Gaia

Quick Links

  • GENAP Summit
    • Why should you attend?
    • Registration
    • Sponsorship
    • Poster Submission
    • Frequently Asked Questions
  • Gallery
    • Photo Report 2023
    • Photo Report 2024
    • Photo Report 2025
  • Location & Travel
    • The Venue 2023
    • The Venue 2024
    • The Venue 2025
  • Contact GENAP Team
Terms & Conditions | Privacy Policy

© 2017 Copyright All Rights Reserved | Powered by EPM Group

GENAP Summit is a brand owned by EPM Group, registered company in Portugal. EU VAT ID PT513501312